Active, not recruitingPhase 1NCT04212416

Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease

Studying Chronic graft versus host disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
City of Hope Medical Center
Principal Investigator
Amandeep Salhotra
City of Hope Medical Center
Intervention
Leflunomide(drug)
Enrollment
18 enrolled
Eligibility
18 years · All sexes
Timeline
2020 – 2026

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04212416 on ClinicalTrials.gov

Other trials for Chronic graft versus host disease

Additional recruiting or active studies for the same condition.

See all trials for Chronic graft versus host disease →

← Back to all trials